Overexpression of miR-182 enhanced HCC metastasis by targeting MTSS1, so research has shown that targeting miR-182 has the opposite effect and enhanced the anti-metastatic properties of MTSS1 (Fig. 2) [57]. This evidence concerns the gene MTSS1 and hepatocellular carcinoma.